Sept 7 (Reuters) - CSL Ltd CSL.AX :
* AGREEMENTS TO MANUFACTURE COVID-19 VACCINES
* HEADS OF AGREEMENT SIGNED BETWEEN CO AND AUSTRALIAN GOVERNMENT TO SUPPLY 51 MILLION DOSES OF UNIVERSITY OF QUEENSLAND VACCINE TO AUSTRALIA
* CSL EXPECTS FIRST TRANCHE OF DOSES TO BE AVAILABLE BY MID-2021
* AGREEMENT SIGNED BETWEEN CO & ASTRAZENECA FOR EXPECTED MANUFACTURE OF ABOUT 30 MILLION DOSES OF OXFORD UNIVERSITY VACCINE CANDIDATE AZD1222
* FUNDING DEED WITH AUSTRALIAN GOVERNMENT AND CSL TO READY ITS FACILITIES FOR MANUFACTURE OF AZD1222 VACCINE CANDIDATE
* UNIVERSITY OF QUEENSLAND CURRENTLY UNDERTAKING A PHASE 1 CLINICAL STUDY ON UQ- CSL V451 TO ASSESS SAFETY AND IMMUNOGENICITY IN HEALTHY VOLUNTEERS
* UNDER AGREEMENT WITH ASTRAZENECA TO MANUFACTURE AZD1222 VACCINE CANDIDATE, FIRST DOSES PLANNED FOR RELEASE TO AUSTRALIA EARLY NEXT YEAR Source ( https:// Further company coverage: CSL.AX